Aztreonam Lysine in CF (AZLI)

The purpose of this study is to observe the effects of aztreonam lysine for inhalation (AZLI, trade name Cayston) on Pseudomonas aeruginosa levels in sputum. We are enrolling patients who take Cayston as part of their usual medication regimen. Sputum is to be collected every two weeks during both the ON and OFF cycles of Cayston, over a span of 58 days. Enrollment is open for this study.

For more information, please contact Eri Flores at (604) 682-2344 ext. 63721 or eflores@providencehealth.bc.ca.